Margarette J Shegog, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 4 carriers
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · Indian Health Center of Santa Clara Valley
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
19 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shegog’s office at (408) 995-5453 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A150203 · Current
Licensed to practise in California · since 2017 · expires 2027-07-31 · Wright State University Boonshoft School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$6,590
Medicare paid this office $6,590 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 72 · Women 49% · Also on Medicaid 58% · Health risk score 1.85. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 36% · Depression 36%.
The office billed $24,944, Medicare allowed $8,435 and paid $6,590; for 78 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 78 | 72 | 1.85 | $24,944 | $6,590 |
| 2023 | 54 | 155 | 71 | 3.31 | $60,573 | $15,431 |
| 2022 | 33 | 129 | 70 | 2.55 | $46,494 | $12,913 |
| 2021 | 18 | 54 | 68 | 0.92 | $5,162 | $1,815 |
| 2020 | 74 | 253 | 70 | 1.54 | $18,983 | $8,487 |
| 2019 | 112 | 258 | 71 | 1.61 | $12,651 | $5,720 |
| 2018 | 232 | 622 | 72 | 1.52 | $72,576 | $17,630 |
| 2017 | 159 | 322 | 67 | 1.38 | $35,707 | $10,939 |
| 2016 | 20 | 60 | 60 | 1.38 | $6,527 | $2,540 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $4,556 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,344 | $156 |
| Hospital discharge day management, more than 30 minutes | 20 | $2,093 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,067 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,402 | $117 |
2022: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $5,526 | $97 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,326 | $95 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,814 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,332 | $86 |
| Testing for presence of drug, read by direct observation | 13 | $826 | $13 |
| Hemoglobin a1c level | 18 | $252 | $10 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,311 | $60 |
| Testing for presence of drug, read by direct observation | 25 | $618 | $12 |
| Hemoglobin a1c level | 46 | $507 | $11 |
| Urinalysis using microscope | 11 | $46 | $3 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $5,567 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,237 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,914 | $159 |
| Hemoglobin a1c level | 92 | $1,716 | $12 |
| Testing for presence of drug, read by direct observation | 50 | $1,477 | $13 |
| Hospital discharge day management, 30 minutes or less | 13 | $774 | $60 |
| Manual urinalysis test with examination using microscope, non-automated | 24 | $130 | $4 |
2017: 7 services
| Return visit (30+ min) | 26 | $2,853 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,354 | $85 |
| Short return visit (20+ min) | 22 | $967 | $42 |
| Hemoglobin a1c level | 49 | $653 | $13 |
| Testing for presence of drug, read by direct observation | 18 | $293 | $15 |
| Blood test, clotting time | 13 | $232 | $5 |
| Insertion of needle into vein for collection of blood sample | 14 | $41 | $3 |
2016: 1 service
| Return visit (30+ min) | 12 | $1,545 | $81 |
Medicaid work
$296,233 in 2024
Medicaid paid $296,233 for 2,951 billed services this clinician did in 2024, up to 169 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,116 | $281,855 |
| Short return visit (20+ min) | 911 | $7,268 |
| Return visit (30+ min) | 845 | $6,644 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 30 | $355 |
| Hemoglobin A1C level | 25 | $111 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 12 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 12 | $0 |
| 2024 | 2,951 | 7 | 169 | $296,233 |
| 2023 | 3,064 | 11 | 147 | $267,627 |
| 2022 | 2,471 | 11 | 137 | $218,978 |
| 2021 | 1,656 | 8 | 145 | $145,148 |
| 2020 | 1,224 | 3 | 38 | $74,398 |
| 2019 | 653 | 4 | 36 | $21,089 |
| 2018 | 786 | 5 | 55 | $34,771 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,093 | $260,365 |
| Return visit (30+ min) | 815 | $2,116 |
| Short return visit (20+ min) | 793 | $1,676 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 78 | $873 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 58 | $580 |
| 1ST HOSP IP/OBS HIGH 75 | 17 | $545 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 53 | $519 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 20 | $401 |
| Long return visit (40+ min) | 89 | $386 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 24 | $90 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 24 | $78 |
2022
| Clinic visit/encounter, all-inclusive | 925 | $214,279 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 113 | $1,461 |
| Return visit (30+ min) | 458 | $799 |
| Short return visit (20+ min) | 764 | $722 |
| 1ST HOSP IP/OBS HIGH 75 | 16 | $646 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 36 | $380 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 68 | $369 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 17 | $260 |
| New patient visit (30+ min) | 20 | $63 |
| Bilateral quantitative screening test of visual acuity | 14 | $0 |
| Short return visit | 40 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 768 | $144,179 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 95 | $619 |
| Pure tone audiometry (threshold); air only | 25 | $129 |
| Return visit (30+ min) | 412 | $113 |
| Short return visit (20+ min) | 267 | $96 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 39 | $13 |
| Bilateral quantitative screening test of visual acuity | 16 | $0 |
| Short return visit | 34 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 689 | $74,042 |
| Return visit (30+ min) | 509 | $304 |
| Short return visit (20+ min) | 26 | $53 |
2019
| Clinic visit/encounter, all-inclusive | 218 | $20,056 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 80 | $742 |
| Short return visit (20+ min) | 212 | $216 |
| Return visit (30+ min) | 143 | $75 |
2018
| Clinic visit/encounter, all-inclusive | 534 | $33,328 |
| Return visit (30+ min) | 146 | $541 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 44 | $346 |
| Short return visit (20+ min) | 50 | $291 |
| Alcohol and/or drug screening | 12 | $264 |
Drugs they prescribed that Part D paid
$108,570
Pharmacies billed $108,570 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
572 generic and fewer than 11 brand-name prescriptions · $108,570 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 11 | $14,100 | $1,282 |
| Levetiracetam Er | 12 | $825 | $69 |
| Duloxetine | 21 | $717 | $34 |
| Pregabalin | 23 | $512 | $22 |
| Levothyroxine | 19 | $447 | $24 |
See all 19 drugs
| Jardiance | 11 | $14,100 | $1,282 |
| Levetiracetam Er | 12 | $825 | $69 |
| Duloxetine | 21 | $717 | $34 |
| Pregabalin | 23 | $512 | $22 |
| Levothyroxine | 19 | $447 | $24 |
| Hydroxyzine | 11 | $435 | $40 |
| Gabapentin | 13 | $306 | $24 |
| Albuterol Sulfate Hfa | 13 | $281 | $22 |
| Rosuvastatin | 14 | $225 | $16 |
| Atorvastatin | 32 | $186 | $6 |
| Metformin | 34 | $174 | $5 |
| Fluticasone Propionate | 23 | $171 | $7 |
| Lisinopril | 32 | $131 | $4 |
| Amlodipine Besylate | 37 | $129 | $3 |
| Losartan | 23 | $122 | $5 |
| Tamsulosin | 13 | $101 | $8 |
| Omeprazole | 12 | $75 | $6 |
| Ibuprofen | 15 | $67 | $4 |
| Hydrochlorothiazide | 13 | $36 | $3 |
Year by year
| 2024 | 680 | 112 | None | None | $108,570 |
| 2023 | 440 | 84 | None | None | $70,735 |
| 2022 | 378 | 85 | None | None | $41,505 |
| 2021 | 1,401 | 141 | None | 16% | $252,829 |
| 2020 | 2,466 | 219 | None | 17% | $379,864 |
| 2019 | 3,528 | 237 | None | 13% | $271,196 |
| 2018 | 4,993 | 282 | 5% (234) | 13% | $479,917 |
| 2017 | 1,617 | 211 | 7% (116) | 13% | $120,678 |
| 2016 | 497 | 74 | None | None | $28,843 |
| 2015 | 423 | 71 | 5% (20) | 16% | $15,824 |
| 2014 | 202 | 42 | None | None | $8,080 |
| 2013 | 34 | 13 | None | None | $1,088 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Prazosin | 17 | $898 | $53 |
| Gabapentin | 23 | $724 | $31 |
| Diclofenac | 16 | $538 | $34 |
| Atorvastatin | 16 | $474 | $30 |
| Levothyroxine | 15 | $333 | $22 |
| Amlodipine Besylate | 21 | $278 | $13 |
| Omeprazole | 18 | $193 | $11 |
| Metformin | 13 | $167 | $13 |
| Lisinopril | 15 | $109 | $7 |
| Hydrochlorothiazide | 22 | $103 | $5 |
2022: 10 drugs
| Bupropion Xl | 12 | $3,696 | $308 |
| Duloxetine | 21 | $1,992 | $95 |
| Aripiprazole | 13 | $1,191 | $92 |
| Gabapentin | 31 | $870 | $28 |
| Escitalopram | 22 | $465 | $21 |
| Atorvastatin | 19 | $295 | $16 |
| Quetiapine | 13 | $288 | $22 |
| Levothyroxine | 12 | $183 | $15 |
| Losartan | 14 | $139 | $10 |
| Amlodipine Besylate | 11 | $85 | $8 |
2021: 42 drugs
| Suboxone | 24 | $7,084 | $295 |
| Buprenorphine-Naloxone | 26 | $6,777 | $261 |
| Bupropion Xl | 37 | $6,525 | $176 |
| Aripiprazole | 20 | $3,618 | $181 |
| Bystolic | 11 | $1,840 | $167 |
| Duloxetine | 35 | $1,668 | $48 |
| Levothyroxine | 78 | $1,241 | $16 |
| Gabapentin | 37 | $1,105 | $30 |
| Buspirone | 21 | $1,043 | $50 |
| Buprenorphine | 27 | $949 | $35 |
| Atorvastatin | 68 | $910 | $13 |
| Ventolin Hfa | 12 | $823 | $69 |
| Famotidine | 23 | $760 | $33 |
| Quetiapine | 13 | $744 | $57 |
| Divalproex | 17 | $741 | $44 |
| Fenofibrate | 13 | $598 | $46 |
| Lamotrigine | 22 | $592 | $27 |
| Pregabalin | 11 | $532 | $48 |
| Tamsulosin | 18 | $487 | $27 |
| Pantoprazole | 20 | $450 | $22 |
| Losartan | 16 | $450 | $28 |
| Risperidone | 21 | $407 | $19 |
| Diclofenac | 12 | $397 | $33 |
| Montelukast | 18 | $392 | $22 |
| Ondansetron Odt | 12 | $383 | $32 |
| Escitalopram | 26 | $357 | $14 |
| Omeprazole | 31 | $344 | $11 |
| Fluticasone Propionate | 23 | $267 | $12 |
| Olanzapine | 11 | $245 | $22 |
| Metoprolol | 17 | $241 | $14 |
| Amlodipine Besylate | 25 | $235 | $9 |
| Simvastatin | 16 | $230 | $14 |
| Metformin Hcl Er | 14 | $193 | $14 |
| Warfarin | 24 | $184 | $8 |
| Trazodone | 16 | $183 | $11 |
| Lisinopril | 26 | $174 | $7 |
| Metformin | 25 | $156 | $6 |
| Metoprolol | 17 | $131 | $8 |
| Citalopram Hbr | 18 | $125 | $7 |
| Topiramate | 19 | $106 | $6 |
| Atenolol | 13 | $92 | $7 |
| Ondansetron | 11 | $79 | $7 |
2020: 62 drugs
| Latuda | 18 | $25,368 | $1,409 |
| Suboxone | 50 | $20,480 | $410 |
| Buprenorphine-Naloxone | 60 | $16,732 | $279 |
| Breo Ellipta | 19 | $7,251 | $382 |
| Symbicort | 15 | $6,264 | $418 |
| Pregabalin | 11 | $4,639 | $422 |
| Bupropion Xl | 55 | $3,266 | $59 |
| Bystolic | 14 | $2,843 | $203 |
| Duloxetine | 71 | $2,502 | $35 |
| Buprenorphine | 25 | $2,368 | $95 |
| Atorvastatin | 141 | $2,126 | $15 |
| Levothyroxine | 78 | $1,982 | $25 |
| Aripiprazole | 27 | $1,750 | $65 |
| Ventolin Hfa | 20 | $1,728 | $86 |
| Gabapentin | 69 | $1,659 | $24 |
| Lamotrigine | 38 | $1,437 | $38 |
| Quetiapine | 26 | $1,382 | $53 |
| Buspirone | 26 | $1,000 | $38 |
| Mirtazapine | 28 | $883 | $32 |
| Prazosin | 13 | $846 | $65 |
| Losartan | 57 | $799 | $14 |
| Diclofenac | 33 | $789 | $24 |
| Ultra-Fine Short Pen Needle | 13 | $622 | $48 |
| Propranolol | 16 | $603 | $38 |
| Famotidine | 28 | $549 | $20 |
| Warfarin | 48 | $399 | $8 |
| Fluticasone Propionate | 38 | $387 | $10 |
| Sertraline | 23 | $385 | $17 |
| Pantoprazole | 34 | $377 | $11 |
| Omeprazole | 48 | $372 | $8 |
| Fluvoxamine Maleate | 22 | $370 | $17 |
| Trazodone | 25 | $359 | $14 |
| Divalproex | 13 | $346 | $27 |
| Simvastatin | 50 | $346 | $7 |
| Metoprolol | 33 | $335 | $10 |
| Escitalopram | 26 | $317 | $12 |
| Potassium Chloride | 17 | $316 | $19 |
| Lisinopril | 43 | $304 | $7 |
| Olopatadine | 13 | $288 | $22 |
| Metformin | 45 | $282 | $6 |
| Risperidone | 19 | $269 | $14 |
| Montelukast | 22 | $259 | $12 |
| Ropinirole | 19 | $236 | $12 |
| Fluoxetine | 13 | $230 | $18 |
| Tamsulosin | 27 | $230 | $9 |
| Metformin Hcl Er | 30 | $224 | $7 |
| Topiramate | 24 | $216 | $9 |
| Citalopram Hbr | 43 | $211 | $5 |
| Pravastatin | 16 | $206 | $13 |
| Amlodipine Besylate | 41 | $190 | $5 |
| Ibuprofen | 15 | $182 | $12 |
| Metoprolol | 37 | $161 | $4 |
| Nortriptyline | 12 | $153 | $13 |
| Hydrochlorothiazide | 30 | $130 | $4 |
| Hydroxyzine Pamoate | 12 | $113 | $9 |
| Atenolol | 16 | $108 | $7 |
| Benazepril | 27 | $103 | $4 |
| Triamterene-Hydrochlorothiazid | 13 | $103 | $8 |
| Furosemide | 16 | $98 | $6 |
| Meloxicam | 25 | $91 | $4 |
| Clonazepam | 15 | $59 | $4 |
| Clopidogrel | 11 | $37 | $3 |
2019: 82 drugs
| Humira | 12 | $66,731 | $5,561 |
| Suboxone | 29 | $9,271 | $320 |
| Symbicort | 17 | $8,472 | $498 |
| Lyrica | 14 | $8,356 | $597 |
| Advair Diskus | 18 | $7,256 | $403 |
| Breo Ellipta | 12 | $6,644 | $554 |
| Lantus Solostar | 20 | $6,323 | $316 |
| Basaglar Kwikpen U-100 | 16 | $4,878 | $305 |
| Spiriva | 11 | $4,790 | $435 |
| Serevent Diskus | 11 | $4,370 | $397 |
| Duloxetine | 71 | $3,966 | $56 |
| Buprenorphine-Naloxone | 19 | $3,618 | $190 |
| Bystolic | 16 | $3,233 | $202 |
| Levothyroxine | 127 | $3,195 | $25 |
| Aripiprazole | 35 | $3,160 | $90 |
| Atorvastatin | 213 | $2,928 | $14 |
| Buspirone | 47 | $1,844 | $39 |
| Bupropion | 41 | $1,827 | $45 |
| Gabapentin | 126 | $1,823 | $14 |
| Propranolol | 50 | $1,603 | $32 |
| Metoprolol | 69 | $1,356 | $20 |
| Diclofenac | 53 | $1,352 | $26 |
| Memantine | 17 | $1,234 | $73 |
| Omeprazole | 87 | $1,177 | $14 |
| Ventolin Hfa | 15 | $1,145 | $76 |
| Tamsulosin | 48 | $1,089 | $23 |
| Bupropion Xl | 29 | $934 | $32 |
| Losartan | 94 | $933 | $10 |
| Mometasone Furoate | 12 | $796 | $66 |
| Metformin Hcl Er | 62 | $791 | $13 |
| Warfarin | 74 | $693 | $9 |
| Trazodone | 50 | $682 | $14 |
| Ultra-Fine Short Pen Needle | 15 | $654 | $44 |
| Mirtazapine | 43 | $635 | $15 |
| Metformin | 93 | $588 | $6 |
| Amlodipine Besylate-Benazepril | 11 | $580 | $53 |
| Rosuvastatin | 13 | $564 | $43 |
| Simvastatin | 60 | $546 | $9 |
| Ranitidine | 37 | $531 | $14 |
| Escitalopram | 20 | $518 | $26 |
| Metoprolol | 83 | $516 | $6 |
| Olanzapine | 16 | $511 | $32 |
| Potassium Chloride | 14 | $493 | $35 |
| Benazepril | 62 | $479 | $8 |
| Famotidine | 35 | $477 | $14 |
| Fluticasone Propionate | 32 | $463 | $14 |
| Lisinopril | 80 | $445 | $6 |
| Quetiapine | 30 | $444 | $15 |
| Venlafaxine Hcl Er | 21 | $443 | $21 |
| Pravastatin | 20 | $433 | $22 |
| Lamotrigine | 39 | $433 | $11 |
| Amitriptyline | 21 | $408 | $19 |
| Amlodipine Besylate | 82 | $393 | $5 |
| Sertraline | 34 | $369 | $11 |
| Oxybutynin Chloride | 16 | $331 | $21 |
| Naproxen | 18 | $324 | $18 |
| Esomeprazole Magnesium | 13 | $306 | $24 |
| Divalproex | 21 | $292 | $14 |
| Citalopram Hbr | 55 | $279 | $5 |
| Doxazosin Mesylate | 11 | $269 | $24 |
| Furosemide | 51 | $268 | $5 |
| Hydrochlorothiazide | 62 | $251 | $4 |
| Fluoxetine | 25 | $234 | $9 |
| Pantoprazole | 37 | $212 | $6 |
| Ropinirole | 24 | $207 | $9 |
| Meclizine | 11 | $206 | $19 |
| Quinapril | 15 | $204 | $14 |
| Montelukast | 22 | $204 | $9 |
| Ibuprofen | 17 | $200 | $12 |
| Meloxicam | 37 | $196 | $5 |
| Paroxetine | 12 | $169 | $14 |
| Atenolol | 17 | $163 | $10 |
| Topiramate | 22 | $156 | $7 |
| Losartan-Hydrochlorothiazide | 18 | $153 | $9 |
| Sumatriptan | 19 | $153 | $8 |
| Bisoprolol | 11 | $134 | $12 |
| Lovastatin | 11 | $129 | $12 |
| Spironolactone | 19 | $116 | $6 |
| Nortriptyline | 14 | $96 | $7 |
| Estradiol | 12 | $78 | $7 |
| Glimepiride | 12 | $76 | $6 |
| Lorazepam | 12 | $49 | $4 |
2018: 104 drugs
| Ofev | 11 | $108,824 | $9,893 |
| Humira | 13 | $69,949 | $5,381 |
| Lyrica | 70 | $38,951 | $556 |
| Advair Diskus | 42 | $18,634 | $444 |
| Suboxone | 30 | $16,394 | $546 |
| Symbicort | 34 | $13,235 | $389 |
| Basaglar Kwikpen U-100 | 31 | $10,251 | $331 |
| Aripiprazole | 47 | $7,602 | $162 |
| Spiriva | 17 | $6,840 | $402 |
| Lantus Solostar | 15 | $6,267 | $418 |
| Januvia | 13 | $6,086 | $468 |
| Xarelto | 11 | $5,558 | $505 |
| Tradjenta | 12 | $4,997 | $416 |
| Duloxetine | 99 | $4,954 | $50 |
| Onglyza | 11 | $4,755 | $432 |
| Divalproex Sodium Er | 26 | $4,106 | $158 |
| Levothyroxine | 162 | $4,082 | $25 |
| Buprenorphine-Naloxone | 27 | $3,737 | $138 |
| Gabapentin | 165 | $2,905 | $18 |
| Diclofenac | 105 | $2,894 | $28 |
| Morphine Sulfate Er | 50 | $2,889 | $58 |
| Atorvastatin | 201 | $2,516 | $13 |
| Bupropion | 54 | $2,397 | $44 |
| Ventolin Hfa | 29 | $2,070 | $71 |
| Methotrexate | 25 | $2,034 | $81 |
| Propranolol | 57 | $1,957 | $34 |
| Hydrocodone-Acetaminophen | 97 | $1,948 | $20 |
| Metoprolol | 70 | $1,779 | $25 |
| Memantine | 29 | $1,658 | $57 |
| Proair Hfa | 19 | $1,573 | $83 |
| Bystolic | 11 | $1,459 | $133 |
| Tamsulosin | 72 | $1,330 | $18 |
| Buspirone | 46 | $1,314 | $29 |
| Omeprazole | 101 | $1,253 | $12 |
| Warfarin | 103 | $1,091 | $11 |
| Fluticasone Propionate | 80 | $1,087 | $14 |
| Ranitidine | 70 | $991 | $14 |
| Digoxin | 18 | $920 | $51 |
| Trazodone | 100 | $895 | $9 |
| Voltaren | 16 | $880 | $55 |
| Potassium Chloride | 35 | $845 | $24 |
| Amitriptyline | 34 | $831 | $24 |
| Metformin | 123 | $827 | $7 |
| Bupropion Xl | 26 | $806 | $31 |
| Prazosin | 14 | $796 | $57 |
| Amlodipine Besylate | 117 | $765 | $7 |
| Metoprolol | 111 | $763 | $7 |
| Oxybutynin Chloride | 19 | $711 | $37 |
| Mirtazapine | 44 | $656 | $15 |
| Benazepril | 77 | $651 | $8 |
| Armour Thyroid | 11 | $639 | $58 |
| Escitalopram | 29 | $638 | $22 |
| Polyethylene Glycol 3350 | 15 | $619 | $41 |
| Naproxen | 34 | $596 | $18 |
| Lisinopril | 100 | $589 | $6 |
| Meloxicam | 90 | $580 | $6 |
| Losartan | 80 | $550 | $7 |
| Montelukast | 41 | $516 | $13 |
| Metformin Hcl Er | 35 | $515 | $15 |
| Simvastatin | 61 | $504 | $8 |
| Ezetimibe | 11 | $498 | $45 |
| Hydrochlorothiazide | 102 | $483 | $5 |
| Venlafaxine | 27 | $428 | $16 |
| Famotidine | 40 | $415 | $10 |
| Synthroid | 12 | $410 | $34 |
| Fluoxetine | 27 | $390 | $14 |
| Sertraline | 26 | $385 | $15 |
| Quinapril | 32 | $383 | $12 |
| Divalproex | 20 | $377 | $19 |
| Pravastatin | 16 | $369 | $23 |
| Sumatriptan | 27 | $351 | $13 |
| Minocycline | 15 | $340 | $23 |
| Paroxetine | 20 | $338 | $17 |
| Oxycodone | 24 | $326 | $14 |
| Losartan-Hydrochlorothiazide | 35 | $326 | $9 |
| Quetiapine | 24 | $323 | $13 |
| Atenolol | 24 | $296 | $12 |
| Clopidogrel | 11 | $282 | $26 |
| Lamotrigine | 31 | $274 | $9 |
| Citalopram Hbr | 48 | $273 | $6 |
| Pioglitazone | 18 | $266 | $15 |
| Ibuprofen | 27 | $250 | $9 |
| Nortriptyline | 29 | $245 | $8 |
| Furosemide | 61 | $245 | $4 |
| Lovastatin | 14 | $234 | $17 |
| Alprazolam | 19 | $234 | $12 |
| Allopurinol | 19 | $225 | $12 |
| Methadone | 29 | $224 | $8 |
| Venlafaxine Hcl Er | 15 | $221 | $15 |
| Topiramate | 24 | $200 | $8 |
| Clonidine | 26 | $196 | $8 |
| Glimepiride | 20 | $183 | $9 |
| Ropinirole | 14 | $174 | $12 |
| Pantoprazole | 34 | $172 | $5 |
| Lorazepam | 39 | $150 | $4 |
| Cyclobenzaprine | 39 | $132 | $3 |
| Tramadol | 16 | $104 | $7 |
| Hydroxyzine Pamoate | 17 | $95 | $6 |
| Donepezil | 14 | $91 | $6 |
| Spironolactone | 12 | $89 | $7 |
| Alendronate | 17 | $78 | $5 |
| Prednisone | 17 | $69 | $4 |
| Carvedilol | 11 | $41 | $4 |
| Triamcinolone Acetonide | 14 | $28 | $2 |
2017: 40 drugs
| Lyrica | 22 | $12,031 | $547 |
| Victoza 3-Pak | 11 | $8,642 | $786 |
| Advair Diskus | 11 | $7,056 | $641 |
| Duloxetine | 30 | $2,452 | $82 |
| Morphine Sulfate Er | 14 | $1,025 | $73 |
| Levothyroxine | 51 | $1,017 | $20 |
| Hydrocodone-Acetaminophen | 56 | $1,015 | $18 |
| Proair Hfa | 14 | $900 | $64 |
| Metoprolol | 34 | $796 | $23 |
| Gabapentin | 48 | $796 | $17 |
| Fenofibrate | 11 | $735 | $67 |
| Diclofenac | 17 | $709 | $42 |
| Atorvastatin | 59 | $648 | $11 |
| Oxycodone | 14 | $453 | $32 |
| Bupropion Hcl Sr | 14 | $381 | $27 |
| Propranolol | 20 | $356 | $18 |
| Omeprazole | 43 | $330 | $8 |
| Fluticasone Propionate | 25 | $327 | $13 |
| Metformin | 49 | $313 | $6 |
| Lisinopril | 47 | $291 | $6 |
| Trazodone | 37 | $284 | $8 |
| Tamsulosin | 17 | $283 | $17 |
| Venlafaxine Hcl Er | 17 | $280 | $16 |
| Pravastatin | 16 | $261 | $16 |
| Ranitidine | 27 | $239 | $9 |
| Meloxicam | 58 | $221 | $4 |
| Lamotrigine | 15 | $173 | $12 |
| Amlodipine Besylate | 19 | $161 | $8 |
| Cyclobenzaprine | 17 | $137 | $8 |
| Warfarin | 19 | $136 | $7 |
| Lorazepam | 37 | $133 | $4 |
| Losartan | 19 | $124 | $7 |
| Mirtazapine | 12 | $123 | $10 |
| Methadone | 12 | $119 | $10 |
| Benazepril | 12 | $118 | $10 |
| Metoprolol | 19 | $96 | $5 |
| Hydrochlorothiazide | 23 | $92 | $4 |
| Simvastatin | 15 | $92 | $6 |
| Ibuprofen | 14 | $71 | $5 |
| Citalopram Hbr | 16 | $62 | $4 |
2016: 12 drugs
| Crestor | 12 | $2,974 | $248 |
| Proair Hfa | 16 | $859 | $54 |
| Fenofibrate | 14 | $689 | $49 |
| Levothyroxine | 24 | $294 | $12 |
| Metoprolol | 23 | $290 | $13 |
| Omeprazole | 20 | $272 | $14 |
| Atorvastatin | 15 | $202 | $13 |
| Tamsulosin | 13 | $180 | $14 |
| Olanzapine | 11 | $136 | $12 |
| Ranitidine | 20 | $94 | $5 |
| Lisinopril | 27 | $79 | $3 |
| Simvastatin | 13 | $65 | $5 |
2015: 8 drugs
| Levothyroxine | 38 | $460 | $12 |
| Hydrochlorothiazide | 16 | $335 | $21 |
| Bupropion Hcl Sr | 16 | $286 | $18 |
| Omeprazole | 15 | $145 | $10 |
| Simvastatin | 21 | $81 | $4 |
| Ibuprofen | 11 | $76 | $7 |
| Meloxicam | 11 | $40 | $4 |
| Lisinopril | 12 | $38 | $3 |
2014: 2 drugs
| Simvastatin | 14 | $67 | $5 |
| Carvedilol | 16 | $56 | $3 |
Money from drug and device companies
$37 in 2019
A payment is not proof that care is biased.
| Allergan | Vraylar | $19 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $18 | 1 payment
|
See all 2 published payments
| Allergan | Meals · 2019-07-02 | Vraylar | $19 |
| Teva Pharmaceuticals USA | Meals · 2019-05-01 | Ajovy | $18 |
Professional record
- NPI
- 1508202821
- Licence
- CA A150203, NC 2015-02341California A150203: Current · expires 2027-07-31
- Trained
- Wright State University Boonshoft School of Medicine, 2013
- Group
- University Healthcare Alliance · Indian Health Center of Santa Clara Valley
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- NC 1508202821
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr Ste 200, San Jose, CA, 95128
- NPI first listed
- 2013-05-14
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3306 Renner Dr, Fortuna, CA, 95540
This office lists an electronic records connection.